The partner of the Chumakov Center for the production of CoviVac announced the suspension of vaccine production
The Nanolek company, a partner of the Chumakov Center for the production of the CoviVac coronavirus vaccine, announced that it had stopped the production of the drug, RBC reports. “Since December 2021, there have been no applications from the Ministry of Health for the supply of a vaccine, the company has not shipped a single dose of CoviVac,” Maxim Stetsyuk, deputy general director of the company, quotes the publication.